167 related articles for article (PubMed ID: 7634364)
21. Surface properties of native human plasma lipoproteins and lipoprotein models.
Massey JB; Pownall HJ
Biophys J; 1998 Feb; 74(2 Pt 1):869-78. PubMed ID: 9533698
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
[TBL] [Abstract][Full Text] [Related]
23. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
Hsu HC; Lee YT; Yeh HT; Chen MF
J Lab Clin Med; 2001 Jun; 137(6):414-21. PubMed ID: 11385362
[TBL] [Abstract][Full Text] [Related]
24. Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins.
Vergès B; Duvillard L; Lagrost L; Vachoux C; Garret C; Bouyer K; Courtney M; Pomié C; Burcelin R
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1245-53. PubMed ID: 24694333
[TBL] [Abstract][Full Text] [Related]
25. Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclasses are preferred targets.
Hofer G; Lichtenberg D; Kostner GM; Hermetter A
Clin Biochem; 1996 Oct; 29(5):445-50. PubMed ID: 8884065
[TBL] [Abstract][Full Text] [Related]
26. The effect of high-density lipoproteins on the formation of lipid/protein conjugates during in vitro oxidation of low-density lipoprotein.
Sangvanich P; Mackness B; Gaskell SJ; Durrington P; Mackness M
Biochem Biophys Res Commun; 2003 Jan; 300(2):501-6. PubMed ID: 12504112
[TBL] [Abstract][Full Text] [Related]
27. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification.
Nenseter MS; Gudmundsen O; Malterud KE; Berg T; Drevon CA
Biochim Biophys Acta; 1994 Jul; 1213(2):207-14. PubMed ID: 8025132
[TBL] [Abstract][Full Text] [Related]
28. Quantitative profiling of endocannabinoids in lipoproteins by LC-MS/MS.
Bilgin M; Bindila L; Graessler J; Shevchenko A
Anal Bioanal Chem; 2015 Jul; 407(17):5125-31. PubMed ID: 25782872
[TBL] [Abstract][Full Text] [Related]
29. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
[TBL] [Abstract][Full Text] [Related]
30. Nitroxide reduction with ascorbic acid in spin labeled human plasma LDL and VLDL.
Kveder M; Pifat G; Pecar S; Schara M; Ramos P; Esterbauer H
Chem Phys Lipids; 1997 Jan; 85(1):1-12. PubMed ID: 9032943
[TBL] [Abstract][Full Text] [Related]
31. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
32. Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.
Sakaguchi S
Microbiol Immunol; 1982; 26(11):1017-34. PubMed ID: 6220193
[TBL] [Abstract][Full Text] [Related]
33. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women.
Kasim-Karakas SE; Lane E; Almario R; Mueller W; Walzem R
Metabolism; 1997 Apr; 46(4):431-6. PubMed ID: 9109849
[TBL] [Abstract][Full Text] [Related]
34. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Mackness M; Arrol S
Atherosclerosis; 1991 Jul; 89(1):49-57. PubMed ID: 1772471
[TBL] [Abstract][Full Text] [Related]
35. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.
Jürgens G; Fell A; Ledinski G; Chen Q; Paltauf F
Chem Phys Lipids; 1995 Aug; 77(1):25-31. PubMed ID: 7586089
[TBL] [Abstract][Full Text] [Related]
36. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
37. Folate: in vitro and in vivo effects on VLDL and LDL oxidation.
McEneny J; Couston C; McKibben B; Young IS; Woodside JV
Int J Vitam Nutr Res; 2007 Jan; 77(1):66-72. PubMed ID: 17685097
[TBL] [Abstract][Full Text] [Related]
38. Simple method for quantifying alpha-tocopherol in low-density+very-low-density lipoproteins and in high-density lipoproteins.
Carcelain G; David F; Lepage S; Bonnefont-Rousselot D; Delattre J; Legrand A; Peynet J; Troupel S
Clin Chem; 1992 Sep; 38(9):1792-5. PubMed ID: 1526016
[TBL] [Abstract][Full Text] [Related]
39. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein.
Thukkani AK; Albert CJ; Wildsmith KR; Messner MC; Martinson BD; Hsu FF; Ford DA
J Biol Chem; 2003 Sep; 278(38):36365-72. PubMed ID: 12869568
[TBL] [Abstract][Full Text] [Related]
40. [Sodium azide--an activator of serum lipoproteins peroxidation].
Formaziuk VE
Vopr Med Khim; 1982; 28(6):110-3. PubMed ID: 7157712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
